| __timestamp | Agios Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 38783000000 |
| Thursday, January 1, 2015 | 35992000 | 42585000000 |
| Friday, January 1, 2016 | 50714000 | 45702000000 |
| Sunday, January 1, 2017 | 71124000 | 46372000000 |
| Monday, January 1, 2018 | 114145000 | 46910000000 |
| Tuesday, January 1, 2019 | 132034000 | 48890000000 |
| Wednesday, January 1, 2020 | 149070000 | 50129000000 |
| Friday, January 1, 2021 | 121445000 | 54559000000 |
| Saturday, January 1, 2022 | 121673000 | 62081000000 |
| Sunday, January 1, 2023 | 119903000 | 105931000000 |
| Monday, January 1, 2024 | 156784000 | 77201000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Dr. Reddy's Laboratories Limited and Agios Pharmaceuticals, Inc. offer a fascinating comparison. Over the past decade, Dr. Reddy's has consistently maintained SG&A expenses at a robust level, peaking in 2023 with a 71% increase from 2014. In contrast, Agios Pharmaceuticals, Inc. has shown a more volatile trend, with a significant 526% rise in SG&A expenses from 2014 to 2020, before stabilizing. This disparity highlights differing strategic approaches: Dr. Reddy's focuses on steady growth, while Agios navigates rapid expansion. The data for 2024 is incomplete, but the trends suggest continued strategic divergence. Investors and analysts should consider these patterns when evaluating operational efficiency and long-term sustainability in the pharmaceutical sector.
Breaking Down SG&A Expenses: Eli Lilly and Company vs Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Agios Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.